News & Events

——

Glorious Moment丨Haibu Pharmaceutical has received multiple honors!

Classification:

Company News

Release time:

2024-11-07

From November 4 to 6, the third Taishan Pharmaceutical Forum and the "2023-2024 Annual Pharmaceutical Industry Information Release Conference" were grandly held in Jinan, Shandong. This forum, themed "Whole Industry, Big Platform, Deep Integration, Common Development," attracted numerous experts, scholars, and business leaders from the pharmaceutical industry at home and abroad to discuss the latest development trends and technological innovation directions in the pharmaceutical health industry. At this forum, Haibu Pharmaceutical received multiple honors due to its strength!

Awarded 3 prizes and returned with glory

Beijing Haibu Pharmaceutical Technology Co., Ltd. was honored as one of the "Top Fifty R&D Companies in the Pharmaceutical Industry for 2023-2024," marking Haibu Pharmaceutical's continuous years of receiving this honor.

Ms. Liu Changru, Chairman & General Manager of Haibu Pharmaceutical, was awarded the important title of "Person Promoting High-Quality Development of the Pharmaceutical Health Industry for 2023-2024."

Haibu Pharmaceutical was awarded as a "Law-abiding and Honest Enterprise in the Pharmaceutical Industry for 2023-2024."

Honor is both an affirmation and a motivation. In the future, Haibu Pharmaceutical will continue to enhance its technical strength, professional level, innovation capability, etc., to provide customers with higher quality products and services while jointly welcoming a more brilliant future for the pharmaceutical health industry.

Beijing Haibu Pharmaceutical Technology Co., Ltd. (referred to as "Haibu Pharmaceutical") was established in 2005 and is a high-tech enterprise with "chemical drug research and development" as its core capability. It has a research and development center in Beijing, an active pharmaceutical ingredient (API) and formulation pilot verification center, and a GMP industrial production base. Mainly engaged inthe technical development and transfer of chemical drugs, MAH research and holding certificates, API-related declarations as well as commercial supply of pharmaceutical intermediates, innovative and improved drug research declaration etc., it has been awarded the title of "Top 20 Chinese Pharmaceutical R&D Companies" for many consecutive years and recognized as a "Beijing Science and Technology Research Development Institution," "National High-tech Enterprise," and "Beijing Yizhuang Enterprise Innovation Center."

Haibu Pharmaceutical has rich experience in R&D transfer production, registration declaration of various dosage forms such as chemical APIs, oral solids, liquid preparations, sterile injections, external preparations etc. The R&D products cover multiple indication areas including anti-tumor, anti-depression, anti-epilepsy, anti-anxiety, cardiovascular cerebrovascular diseases, digestive system diseases, respiratory system diseases.

[Haibu Pharmaceutical] Pregabalin oral solution has successfully been selected in the tenth batch of national centralized procurement!

【Announcement】Beijing Haibu Pharmaceutical Technology Co., Ltd. Hazardous Waste Pollution Prevention and Control Information Announcement

[Haibu Pharmaceutical] Pregabalin oral solution has successfully been selected in the tenth batch of national centralized procurement!

【Announcement】Beijing Haibu Pharmaceutical Technology Co., Ltd. Hazardous Waste Pollution Prevention and Control Information Announcement

Beijing Hope Pharmaceutical Co., Ltd.

SEO

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.